The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and/or obstetrical manifestations and the persistent presence, at least 12 weeks …

The antiphospholipid syndrome (APS) manifests through venous or arterial thrombosis, with
or without pregnancy complication alongside the continuous presence of antiphospholipid …

Antiphospholipid syndrome (APS) is a clinical condition that has not been well defined yet.
Although the clinical component is well established, the laboratory part is a mood issue …

The laboratory diagnosis of the antiphospholipid syndrome (APS) via antiphospholipid
antibody (aPL) tests, including lupus anticoagulant (LAC), anti-cardiolipin (aCL), or anti …

The laboratory criteria (lupus anticoagulants (LA), and/or anti-cardiolipin (aCL) antibodies
and/or anti-β2-glycoprotein I antibodies (aβ2GPI)) that define patients with antiphospholipid …

The antiphospholipid syndrome (APS) is characterized by thrombosis and/or specific
pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPL) …

Currently, we use the classification criteria for antiphospholipid syndrome (APS) formulated
during the consensus conference in Sapporo and revised in Sydney 1. Classification criteria …

Antiphospholipid antibodies (aPLs) are associated with arterial and venous thrombosis,
recurrent pregnancy loss and thrombocytopenia. Although aPLs have not yet been …

Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the presence of
characteristic clinical features and specified levels of circulating antiphospholipid antibodies …